Infection surveillance solution helps healthcare facilities in
reporting patient-associated data to the state and federal
authorities. Integration of infection surveillance software with
already existing networks of medical facilities and hospitals is an
easy process. A recent report published by Persistence Market
Research (PMR) estimates the global infection
surveillance solution market to register a staggering 14.04% CAGR
during the forecast- 2017 to 2025. The US$ 316.67 Mn market is likely
to surpass US$ 900 Mn in revenues by 2025-end.
Increased Healthcare-associated Infections to Drive the Adoption of
Infection Surveillance Solution
Contamination of devices & equipment, patient clothing, and bed
linens have led to various hospital-associated infections including
pneumonia, urinary tract infection, and surgical site infection. To
identify the possible healthcare associated infections, hospitals and
healthcare professionals are being impelled to adopt infection
surveillance systems. Healthcare institutes are incorporating
infection surveillance systems to seek accurate, real-time
information related to medical records, surgical database, employees’
health and patient health. The aforementioned factors are driving the
growth of the global infection surveillance solution market.
Governments of various economies are encouraging health communication
programs within health institutes. These governments are coming up
with initiatives for building a reliable data source. This further
would help in exchanging information within healthcare systems. In
addition, the capacity of IT systems is witnessing a surge in
performing analytic processing. These factors are expected to aid in
the development of analytical and infection surveillance solutions.
However, improper data management, soaring volume of data for
analysis coupled with altering regulatory requirements, and rising
trend of healthcare staff migration on international level are key
restrains expected to inhibit the market growth over the forecast
period.
Hospitals to be the Most Lucrative End User in the Market
Among end users, hospitals will be the most lucrative in the global
infection surveillance solution market. Revenues amassed from
hospitals would reach around US$ 500 Mn by 2025-end. Clinics, the
second largest end-user, are expected to exhibit 14.19% CAGR through
2025. Although software component is projected to be most lucrative
over the global infection surveillance solution market, the services
component is projected to register a comparatively faster growth
during the forecast period. Infection and surveillance software
enables clinics and hospitals to minimize and control
healthcare-associated infections in real-time.
View To View Table Of Content @
North America to be Dominant in the Global Infection Surveillance
Solution Market
PMR’s report projects North America to remain dominant in the
market during the forecast period, followed by Europe and Asia
Pacific (APAC). The United States (U.S.) is expected to be the most
lucrative country in North America infection surveillance solution
market. Federal regulation in North America have driven the adoption
of infection surveillance solutions by hospitals and other healthcare
settings. Europe and APAC are anticipated to exhibit 13.86% and
13.10% CAGRs respectively through 2025. Government initiatives and
programs in Europe, for example- European Influenza Surveillance
Scheme by European Center for Disease and Prevention Control, are
fuelling the growth of the market in this region.
View Report Table of Contents, Figures, and Tables
Key players identified in PMR’s report include Becton Dickson &
Company, Baxter International, Premier, Inc., Truven Health Analytics
Inc. (IBM Watson), Gojo Industries, Inc., RL Solutions, Wolters
Kluwer N.V., Vigilanz Corporation, Atlas Medical Software (Rpoer
Technologies), Quantros, Inc., BD Diagnostics, ICNet Systems, Inc.
(Baxter International), Vecna Technologies, Inc., bioMerieux, Inc.,
Hygreen Inc., Emerald Health Information Systems Ltd, DEB Group Ltd.,
Iatric Systems, Inc., PeraHealth Inc., and Cerner Corporation.
Browse Report Overview @
No comments:
Post a Comment